Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Más filtros










Intervalo de año de publicación
1.
Open Access Emerg Med ; 14: 299-309, 2022.
Artículo en Inglés | MEDLINE | ID: mdl-35789812

RESUMEN

Syncope is a clinical picture that can affect all age groups and has an important place in admissions to the emergency department. There is an important diagnostic challenge in cases where there are different clinical presentations and patients cannot express the situation clearly. Although the emergency department facilities for the diagnosis of syncope are limited, the diagnosis of many patients can be differentiated from life-threatening conditions with a detailed history and physical examination. High-risk patients should be identified and directed for definitive treatment by emergency medicine physicians. This review contains information about the management of the syncope patient in the emergency department.

2.
Prehosp Disaster Med ; 37(5): 698-700, 2022 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-35851434

RESUMEN

The coronavirus disease 2019 (COVID-19) pandemic has affected millions of people around the globe and vaccines against the disease have started to develop. Side effects of the vaccine have been reported in the literature, including myocarditis, which has a very low incidence and with a good prognosis. This case report aims to present two medical students' vaccine-induced myocarditis cases after the first doses of BNT162b2.These patients were young males with no previous medical history and both of them had good recovery after the disease. Both of them had their vaccine very recently before the event. These cases show that myocarditis can be seen after the first dose as well.Global vaccination is the most effective prevention method against COVID-19. Considering the fact that morbidities after the disease occur more than the side effects of the vaccine, they are still the best option against the current pandemic.


Asunto(s)
COVID-19 , Vacunas contra la Influenza , Gripe Humana , Miocarditis , Vacuna BNT162 , COVID-19/prevención & control , Humanos , Gripe Humana/epidemiología , Masculino , Miocarditis/inducido químicamente
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...